Inicure have been granted support from VINNOVA Planeringsbidrag to improve our EIC Transition proposal. Inicure is coordinating a consortia for collaboration between LIOS, Queen Mary Hospital University London and Swansea University for a joing program to characterise and mature Inicures candidate therapies to boost the Innate immune system as novel therapy to cure resistant infections in a joint project called iCURE. The EIC Transition application will be competed and submitted in mid september 2025.